ATARA BIOTHERAPEUTICS, INC.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $8.5M | $25.0M | $25.8M | $92.9M | $106.1M | $200.4M | $74.3M | $60.7M |
| Accounts Receivable | $1.3M | $1.5M | $34.1M | $40.2M | $986.0K | $1.3M | $0 | — |
| Inventory | $0 | $10.7M | $9.7M | $1.6M | $0 | — | — | — |
| Total Current Assets | $12.2M | $64.9M | $101.9M | $295.1M | $384.6M | $523.3M | $273.0M | $321.5M |
| Property, Plant & Equipment | $73.0K | $1.3M | $3.9M | $6.3M | $53.8M | $50.5M | $54.2M | $68.6M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $20.2M | $109.1M | $165.5M | $376.4M | $468.1M | $588.1M | $342.9M | $391.8M |
| Liabilities | ||||||||
| Accounts Payable | $127.0K | $4.4M | $3.7M | $6.9M | $17.4M | $7.1M | $8.0M | $3.7M |
| Total Current Liabilities | $14.9M | $134.6M | $142.2M | $78.9M | $105.8M | $82.9M | $36.7M | $40.0M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $58.7M | $206.4M | $264.7M | $249.8M | $188.5M | $125.8M | $52.2M | $53.0M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-2.02B | $-2.05B | $-1.97B | $-1.69B | $-1.46B | $-1.12B | $-818.0M | $-527.3M |
| Total Stockholders' Equity | $-38.5M | $-97.3M | $99.2M | $126.6M | $279.6M | $462.3M | $290.8M | $339.2M |